HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $981,000 | -18.4% | 20,118 | -18.6% | 0.17% | +26.9% |
| Q1 2022 | $1,202,000 | +14.2% | 24,702 | 0.0% | 0.13% | -11.8% |
| Q4 2021 | $1,053,000 | -8.8% | 24,702 | -17.9% | 0.15% | +15.2% |
| Q3 2021 | $1,154,000 | +20.7% | 30,101 | -11.1% | 0.13% | +24.5% |
| Q2 2021 | $956,000 | – | 33,853 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |